Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | F7 | P08709 | 3/20 | 0.46 |
| ▸ | F3 | P13726 | 3/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.46 |
| ▸ | PPARG | P37231 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | PPARD | Q03181 | 2/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13883684 | 0.93 | ALDH1A1 (0.54) | ALDH1A1ENPP2LPAR2 | |
| SCHEMBL899230 | 0.89 | ALDH1A1 (0.68) | ALDH1A1ENPP2LPAR2 | |
| SCHEMBL18327149 | 0.89 | ALDH1A1 (0.68) | ALDH1A1ENPP2LPAR2 | |
| SCHEMBL899229 | 0.89 | ALDH1A1 (0.68) | ALDH1A1ENPP2LPAR2 | |
| SCHEMBL28910536 | 0.86 | ALDH1A1 (0.62) | ALDH1A1F7F3CYP19A1CYP3A4 | |
| SCHEMBL18327147 | 0.83 | ALDH1A1 (0.76) | ALDH1A1ENPP2LPAR2 | |
| SCHEMBL5839131 | 0.83 | ALDH1A1 (0.76) | ALDH1A1ENPP2LPAR2 | |
| SCHEMBL30958398 | 0.83 | ALDH1A1 (0.76) | ALDH1A1ENPP2LPAR2 | |
| SCHEMBL28705358 | 0.83 | ALDH1A1 (0.63) | ALDH1A1ENPP2LPAR2 | |
| SCHEMBL18327140 | 0.83 | ALDH1A1 (0.76) | ALDH1A1ENPP2LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029790-B2 | Biomimetic nanomaterials and uses thereof | OHIO STATE INNOVATION FOUNDATION (US) | 2024-07-09 | — | — | US | disclosed |
| US-20230338577-A1 | ALKENYL SUBSTITUTED 2,5-PIPERAZINEDIONES, COMPOSITIONS, AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-10-26 | — | — | US | disclosed |
| US-11679165-B2 | Alkenyl substituted 2,5-piperazinediones, compositions, and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-06-20 | — | — | US | disclosed |
| US-20160367686-A1 | ALKENYL SUBSTITUTED 2,5-PIPERAZINEDIONES, COMPOSITIONS, AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2016-12-22 | — | — | US | disclosed |
| US-20160367686-A1 | ALKENYL SUBSTITUTED 2,5-PIPERAZINEDIONES, COMPOSITIONS, AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2016-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12029790-B2 | Biomimetic nanomaterials and uses thereof | MTREX, HAVCR2, TSG101 | ALDH1A1 2146/4885F7 3334/4885F3 3281/4885 |
| US-11679165-B2 | Alkenyl substituted 2,5-piperazinediones, compositions, and uses thereof | UGT1A10, AKR1B10, CCR10 | ALDH1A1 12/4885F7 1821/4885F3 969/4885 |
| US-20160367686-A1 | ALKENYL SUBSTITUTED 2,5-PIPERAZINEDIONES, COMPOSITIONS, AND USES THEREOF | UGT1A10, AKR1B10, CCR10 | ALDH1A1 12/4885F7 1821/4885F3 969/4885 |
| US-20230338577-A1 | ALKENYL SUBSTITUTED 2,5-PIPERAZINEDIONES, COMPOSITIONS, AND USES THEREOF | UGT1A10, AKR1B10, CCR10 | ALDH1A1 12/4885F7 1821/4885F3 969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.